{"doc_id": "PMID-9710149.txt", "sent_id": "S1", "tokens": ["Dimethyldithiocarbamate", "inhibits", "in", "vitro", "activation", "of", "primary", "human", "CD4", "+", "T", "lymphocytes", "."], "sentence": "Dimethyldithiocarbamate inhibits in vitro activation of primary human CD4 + T lymphocytes .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "CD4", "entity_type": "Protein", "start": 8, "end": 8}]}
{"doc_id": "PMID-9710149.txt", "sent_id": "", "tokens": ["Dithiocarbamates", "(", "DTC", ")", ",", "a", "diverse", "group", "of", "industrial", "and", "therapeutic", "chemicals", ",", "have", "been", "reported", "to", "inhibit", ",", "enhance", "or", "have", "no", "effect", "on", "the", "immune", "system", "."], "sentence": "Dithiocarbamates ( DTC ) , a diverse group of industrial and therapeutic chemicals , have been reported to inhibit , enhance or have no effect on the immune system .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9710149.txt", "sent_id": "", "tokens": ["These", "apparent", "inconsistencies", "reflect", "the", "complexity", "of", "the", "DTCs", "biological", "activities", "and", "are", "probably", "due", "in", "part", "to", "differences", "in", "dose", ",", "route", "of", "exposure", ",", "animal", "species", "used", "and", "/", "or", "specific", "compound", "tested", "."], "sentence": "These apparent inconsistencies reflect the complexity of the DTCs biological activities and are probably due in part to differences in dose , route of exposure , animal species used and / or specific compound tested .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9710149.txt", "sent_id": "", "tokens": ["The", "studies", "described", "herein", "were", "undertaken", "to", "investigate", "the", "immunotoxicity", "of", "one", "member", "of", "this", "family", ",", "dimethyldithiocarbamate", "(", "DMDTC", ")", "."], "sentence": "The studies described herein were undertaken to investigate the immunotoxicity of one member of this family , dimethyldithiocarbamate ( DMDTC ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9710149.txt", "sent_id": "S5", "tokens": ["We", "demonstrate", "that", "0.1-0.5", "microM", "DMDTC", "inhibits", "TNF-alpha", "-", "induced", "activation", "of", "NF-kappaB", "in", "primary", "human", "CD4", "+", "T", "cells", "."], "sentence": "We demonstrate that 0.1-0.5 microM DMDTC inhibits TNF-alpha - induced activation of NF-kappaB in primary human CD4 + T cells .", "event_mentions": [], "entity_mentions": [{"id": "T2", "text": "TNF-alpha", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T3", "text": "CD4", "entity_type": "Protein", "start": 16, "end": 16}]}
{"doc_id": "PMID-9710149.txt", "sent_id": "", "tokens": ["This", "inhibition", "is", "not", "accompanied", "by", "a", "loss", "in", "viability", ",", "and", "DMDTC", "-", "treated", "T", "cells", "retain", "other", "active", "signaling", "pathways", "throughout", "the", "exposure", "duration", "."], "sentence": "This inhibition is not accompanied by a loss in viability , and DMDTC - treated T cells retain other active signaling pathways throughout the exposure duration .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9710149.txt", "sent_id": "S7", "tokens": ["The", "inhibition", "of", "NF-kappaB", "is", "apparently", "permanent", "as", "DMDTC", "-", "treated", "T", "cells", "did", "not", "regain", "normal", "TNF-alpha", "activation", ",", "even", "after", "72", "h", "in", "culture", "."], "sentence": "The inhibition of NF-kappaB is apparently permanent as DMDTC - treated T cells did not regain normal TNF-alpha activation , even after 72 h in culture .", "event_mentions": [{"id": "E1", "event_type": "Positive_regulation", "trigger": {"text": "regain", "start": 15, "end": 15}, "arguments": [{"entity_id": "T8", "text": "activation", "role": "Theme"}]}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 18, "end": 18}, "arguments": [{"entity_id": "T4", "text": "TNF-alpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T4", "text": "TNF-alpha", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T7", "text": "regain", "entity_type": "Positive_regulation", "start": 15, "end": 15}, {"id": "T8", "text": "activation", "entity_type": "Positive_regulation", "start": 18, "end": 18}]}
{"doc_id": "PMID-9710149.txt", "sent_id": "", "tokens": ["DMDTC", "does", "not", "appear", "to", "alter", "NF-kappaB", "directly", "as", "pre-incubation", "of", "nuclear", "extracts", "with", "DMDTC", "does", "not", "diminish", "binding", "activity", "of", "this", "protein", "."], "sentence": "DMDTC does not appear to alter NF-kappaB directly as pre-incubation of nuclear extracts with DMDTC does not diminish binding activity of this protein .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9710149.txt", "sent_id": "S9", "tokens": ["We", "further", "demonstrate", "that", "0.1-0.5", "microM", "DMDTC", "inhibits", "intracellular", "IL-2", "production", "and", "decreases", "surface", "expression", "of", "CD25", "(", "the", "alpha", "subunit", "of", "the", "IL-2", "receptor", ")", "in", "T", "cells", "stimulated", "with", "phorbol", "ester", "."], "sentence": "We further demonstrate that 0.1-0.5 microM DMDTC inhibits intracellular IL-2 production and decreases surface expression of CD25 ( the alpha subunit of the IL-2 receptor ) in T cells stimulated with phorbol ester .", "event_mentions": [{"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 7, "end": 7}, "arguments": [{"entity_id": "T10", "text": "production", "role": "Theme"}]}, {"id": "E4", "event_type": "Gene_expression", "trigger": {"text": "production", "start": 10, "end": 10}, "arguments": [{"entity_id": "T5", "text": "IL-2", "role": "Theme"}]}, {"id": "E5", "event_type": "Negative_regulation", "trigger": {"text": "decreases", "start": 12, "end": 12}, "arguments": [{"entity_id": "T12", "text": "expression", "role": "Theme"}]}, {"id": "E6", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 14, "end": 14}, "arguments": [{"entity_id": "T6", "text": "CD25", "role": "Theme"}]}], "entity_mentions": [{"id": "T5", "text": "IL-2", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T6", "text": "CD25", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T9", "text": "inhibits", "entity_type": "Negative_regulation", "start": 7, "end": 7}, {"id": "T10", "text": "production", "entity_type": "Gene_expression", "start": 10, "end": 10}, {"id": "T11", "text": "decreases", "entity_type": "Negative_regulation", "start": 12, "end": 12}, {"id": "T12", "text": "expression", "entity_type": "Gene_expression", "start": 14, "end": 14}]}
{"doc_id": "PMID-9710149.txt", "sent_id": "", "tokens": ["These", "data", "demonstrate", "that", "DMDTC", "is", "a", "potent", "immunosuppressive", "compound", "in", "vitro", "."], "sentence": "These data demonstrate that DMDTC is a potent immunosuppressive compound in vitro .", "event_mentions": [], "entity_mentions": []}
